United States
Canada
Latin America
Europe: Member state of EU
Europe: Non-member state of EU
Europe: Norway, Switzerland and UK
Africa
Asia: Other than South Korea and Singapore
South Korea
Singapore
Oceania
the others
Carcinoembryonic antigen (CEA)-producing human pancreatic ilet cell carcinoma cell line.
Other Name
Animal
human
Strain
Genus
Homo
Species
sapiens
Sex
M
Age
61-year-old
Identity
available
Tissue for Primary Cancer
pancreas
Case history
pancreatic carcinoma of islet cell (somatostatinoma)
Metastasis
No
Tissue Metastasized
Genetics
Modal chromosome number is 50. CEA production.
Life Span
infinite
Crisis PDL
Morphology
epithelial-like
Character
Cell line produces carcinoembryonic antigen (CEA). Cells create irregular cell aggregates, and grow as a confluent monolayer with piling up of cells in some area. Population doubling time is 3.5 days. Useful to study the regulation mechanisms of SRIF.
Classify
tumor
Established by
Kaku,M. et.al.
Registered by
Iguchi,H.
Regulation for Distribution
Comment
Cells are observed to be unique from the STR-PCR analysis.
Year
2001
Medium
RPMI1640 medium with 10% fetal bovine serum.
Methods for Passages
Trypsin treatment.
Cell Number on Passage
5 x 10^5 cells/35mm dish
Race
Japanese
CO2 Conc.
Tissue Sampling
islet cell of pancreas
Tissue Type
Detection of virus genome fragment by Real-time PCR
Detected DNA Virus
tested
Detected RNA Virus
tested
CMV
-
parvoB19
-
HCV
-
HTLV-1
-
EBV
-
HBV
-
HIV-1
-
HTLV-2
-
HHV6
-
HTLV-1
-
HIV-2
-
HAV
-
HHV7
-
HTLV-2
-
-/negative.
+/positive.
nt/not tested.
(positive (+) does not immediately mean the production of infectious viral particles.)
A somatostatin-secreting cell line established from a human pancreatic islet cell carcinoma (somatostatinoma): release experiment and immunohistochemical study. Iguchi H,Hayashi I,Kono A Cancer Res. 1990 Jun 15;50(12):3691-3
Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma. Kaku M,Nishiyama T,Yagawa K,Abe M Gan. 1980 Oct;71(5):596-601